Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Giant Biogene Holding Co., Ltd. (2367.HK)

80.200
+1.250
+(1.58%)
At close: 4:08:06 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Jianya Yan CEO & Executive Chairman of the Board 743.9k -- 1966
Ms. Huijuan Zhang CFO & Executive Director 237.32k -- 1987
Dr. Daidi Fan Chief Scientific Officer -- -- 1967
Ms. Juan Ye Senior VP & Executive Director 938.66k -- 1972
Ms. Juan Fang Senior VP & Executive Director 940.79k -- 1974
Ms. Yajuan Yan Senior Vice President -- -- 1970
Ms. Yubo Yan Chief Product Officer, Joint Company Secretary & Executive Director 148.99k -- 1996
Mr. Zhiguang Duan Senior Vice President -- -- 1982
Ms. Wing Yan Yuen FCIS, FCS Joint Company Secretary -- -- 1970

Giant Biogene Holding Co., Ltd.

No. 1855, Shanglin Yuan
7th Road Chang’an District
Xi'an
China
86 29 8115 6502 https://www.xajuzi.com
Full Time Employees: 
1,758

Description

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.

Corporate Governance

Giant Biogene Holding Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 26, 2025 at 10:59 AM UTC

Giant Biogene Holding Co., Ltd. Earnings Date

June 17, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers